Top Markets
#1 Siren Siren +34.84%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.77%
#3 Ribbita by Virtuals Ribbita by Virtuals +20.39%
#4 Wiki Cat Wiki Cat +20.32%
#5 Cysic Cysic +17.69%
#6 Velvet Velvet +17.23%
#7 PulseChain PulseChain +16.52%
#8 KUB Coin KUB Coin +16.41%
#9 BasedHype BasedHype +14.69%
#10 PulseX PulseX +14.18%
Coin of the day
Siren Siren
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
VentriPoint Diagnostics Ltd. VentriPoint Diagnostics Ltd.

VentriPoint Diagnostics Ltd.

VPT
Classifica tra le azioni #31083
VentriPoint Diagnostics Ltd. is a medical technology company focused on... VentriPoint Diagnostics Ltd. is a medical technology company focused on developing and commercializing diagnostic tools worldwide. These innovative solutions are designed to monitor individuals afflicted with cardiovascular disease. At the core of their offerings is the Ventripoint Medical System (VMS), an advanced medical imaging platform. The VMS generates precise three-dimensional models of the heart's chambers, providing crucial volumetric and functional measurements. This system is further enhanced by its VMS+ software, which processes echocardiogram and magnetic resonance imaging (MRI) data to construct these 3D models. The VMS+ software ensures highly reproducible and accurate quantification of heart chamber volumes and ejection fraction. Beyond its current flagship system, VentriPoint Diagnostics is actively expanding its portfolio with a suite of specialized applications. These applications target various cardiac conditions and imaging techniques, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and heart complications stemming from Covid-19. Founded in 2004, the company operates from its headquarters in Toronto, Canada.
Prezzo delle azioni
$0.07706337
Capitalizzazione di mercato
$14.46M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-3.33%
Paese
CA
Scambia VentriPoint Diagnostics Ltd. (VPT)

Categoria

Healthcare
Ricavi di VentriPoint Diagnostics Ltd. (VPT)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di VentriPoint Diagnostics Ltd., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per VentriPoint Diagnostics Ltd. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US